1Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptorCarolina Castillo Hernández, Carlos Felipe Burgos, Angela Hidalgo Gajardo, Tiare Silva-Grecchi, Javiera Gavilan, Jorge Roberto Toledo, Jorge Fuentealba1381-13892Autonomic dysreflexia: a cardiovascular disorder following spinal cord injuryHisham Sharif, Shaoping Hou1390-14003Odorants could elicit repair processes in melanized neuronal and skin cellsBarbara Pavan, Alessandro Dalpiaz1401-14044Post electrical or lightning injury syndrome: a proposal for an American Psychiatric Association's Diagnostic and Statistical Manual formulation with implications for treatmentChristopher J. Andrews, Andrew D. Reisner, Mary Ann Cooper1405-14125Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant modelsTao Lu, Paul Kim, Yu Luo1413-14176Therapeutic potential of α7 nicotinic receptor agonists to regulate neuroinflammation in neurodegenerative diseasesLaura Foucault-Fruchard, Daniel Antier1418-14217Promises and pitfalls of immune-based strategies for Huntington's diseaseGabriela Delevati Colpo, Erin Furr Stimming, Natalia Pessoa Rocha, Antonio Lucio Teixeira1422-14258How the brain can rewire itself after an injury: the lesson from hemispherectomyLuca Sebastianelli, Leopold Saltuari, Raffaele Nardone1426-14279Relevance and therapeutic potential of CypA targeting to block apoptosis inducing factor-mediated neuronal cell deathNunzianna Doti, Menotti Ruvo1428-142910Extracellular matrix based biomaterials for central nervous system tissue repair: the benefits and drawbacksSarka Kubinova1430-143211Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson's diseaseBj?rn Spittau1433-143412SLP-2: a potential new target for improving mitochondrial function in Parkinson's diseaseAlessandra Zanon, Andrew A. Hicks, Peter P. Pramstaller, Irene Pichler1435-143613Can we switch production of toxic Aβ oligomers to neuroprotective Aβ monomers to allow synapse regeneration?Clive Bate1437-143814Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's diseaseAlba Di Pardo, Vittorio Maglione1439-144015DNA damage and neurodegeneration:the unusual suspectDaniel Stein, Debra Toiber1441-144216Constraint-induced movement therapy in treatment of acute and sub-acute stroke: a meta-analysis of 16 randomized controlled trialsXi-hua Liu, Juan Huai, Jie Gao, Yang Zhang, Shou-wei Yue1443-145017Therapeutic efficacy and safety of various botulinum toxin A doses and concentrations in spastic foot after stroke: a randomized controlled trialJiang Li, Ru Zhang, Bo-li Cui, Yong-xiang Zhang, Guang-tao Bai, Si-shan Gao, Wen-jian Li1451-145718Effect of hyperthermia on calbindin-D 28k immunoreactivity in the hippocampal formation following transient global cerebral ischemia in gerbilsJae-Chul Lee, Jeong-Hwi Cho, Tae-Kyeong Lee, In Hye Kim, Moo-Ho Won, Geum-Sil Cho, Bich-Na Shin, In Koo Hwang, Joon Ha Park, Ji Hyeon Ahn, Il Jun Kang, Young Joo Lee, Yang Hee Kim1458-146419Corticoreticular tract lesion in children with developmental delay presenting with gait dysfunction and trunk instabilityYong Min Kwon, Jessica Rose, Ae Ryoung Kim, Su Min Son1465-147120Extracellular signal-regulated kinase, substance P and neurokinin-1 are involved in the analgesic mechanism of herb-partitioned moxibustionZhi-yuan Li, Yan-ting Yang, Jue Hong, Dan Zhang, Xiao-fei Huang, Li-jie Wu, Huan-gan Wu, Zheng Shi, Jie Liu, Yi Zhu, Xiao-peng Ma1472-1478 